These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31243813)

  • 1. Bif-1/Endophilin B1/SH3GLB1 regulates bone homeostasis.
    Touyama K; Khan M; Aoki K; Matsuda M; Hiura F; Takakura N; Matsubara T; Harada Y; Hirohashi Y; Tamura Y; Gao J; Mori K; Kokabu S; Yasuda H; Fujita Y; Watanabe K; Takahashi Y; Maki K; Jimi E
    J Cell Biochem; 2019 Nov; 120(11):18793-18804. PubMed ID: 31243813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.
    Arai A; Mizoguchi T; Harada S; Kobayashi Y; Nakamichi Y; Yasuda H; Penninger JM; Yamada K; Udagawa N; Takahashi N
    J Cell Sci; 2012 Jun; 125(Pt 12):2910-7. PubMed ID: 22454522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4
    Goto Y; Aoyama M; Sekiya T; Kakita H; Waguri-Nagaya Y; Miyazawa K; Asai K; Goto S
    Stem Cells; 2016 Nov; 34(11):2733-2743. PubMed ID: 27339271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
    Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of stress-associated gene
    Shiraki M; Xu X; Iovanna JL; Kukita T; Hirata H; Kamohara A; Kubota Y; Miyamoto H; Mawatari M; Kukita A
    FASEB J; 2019 Aug; 33(8):8836-8852. PubMed ID: 31067083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
    Dela Cruz A; Grynpas MD; Mitchell J
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation.
    Lee J; Youn BU; Kim K; Kim JH; Lee DH; Seong S; Kim I; Han SH; Che X; Choi JY; Park YW; Kook H; Kim KK; Lim DS; Kim N
    J Bone Miner Res; 2015 Sep; 30(9):1597-607. PubMed ID: 25761670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
    Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT
    Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of osteoblastic Arl6ip5 impaired osteoblast differentiation and enhanced osteoclastogenesis via disturbance of ER calcium homeostasis and induction of ER stress-mediated apoptosis.
    Wu Y; Yang M; Fan J; Peng Y; Deng L; Ding Y; Yang R; Zhou J; Miao D; Fu Q
    Cell Death Dis; 2014 Oct; 5(10):e1464. PubMed ID: 25321471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice.
    Singh K; Piprode V; Mhaske ST; Barhanpurkar-Naik A; Wani MR
    J Immunol; 2018 Jan; 200(2):595-606. PubMed ID: 29203513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.
    Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U
    Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF family member-associated NF-κB activator (TANK) induced by RANKL negatively regulates osteoclasts survival and function.
    Wu M; Wang Y; Deng L; Chen W; Li YP
    Int J Biol Sci; 2012; 8(10):1398-407. PubMed ID: 23139637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation.
    Maruyama K; Kawagoe T; Kondo T; Akira S; Takeuchi O
    J Biol Chem; 2012 Aug; 287(34):29114-24. PubMed ID: 22773835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
    Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y
    Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.
    Khalid AB; Slayden AV; Kumpati J; Perry CD; Berryhill SB; Crawford JA; Fatima I; Morselli M; Pellegrini M; Miranda-Carboni GA; Krum SA
    Bone; 2018 Nov; 116():78-86. PubMed ID: 30031905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.